Skip to content
Search

Latest Stories

Submit Guest Post

Lib Dem leader Ed Davey visits Day Lewis pharmacy in south London

Lib Dem leader Ed Davey visits Day Lewis pharmacy in south London

SIR ED DAVEY, leader of the Liberal Democrats, this week visited a Day Lewis branch in south London to hear first hand from the pharmacy staff about the vital services they offer in their local community.

He extended his thanks to all those working in community pharmacies for their ongoing efforts to support local communities through the Covid-19 pandemic.


Rupa Patel, the executive director of Day Lewis Pharmacy, later said that the Lib Dem leader showed great interest in community pharmacy and was hugely impressed by the various services it provided.

Sir Ed was equally impressed by how accessible pharmacies are and was in for a surprise when he witnessed a few people walk into the Day Lewis branch in New Malden for their flu jabs while he was in the pharmacy.

The 2021-22 flu vaccination programme began in September and will run until March.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Artificial Intelligence in hiring

US lawmakers are pushing for stronger safeguards as AI systems become more powerful

iStockphoto

After a rogue AI incident, US lawmakers want the power to pull the plug

  • US lawmakers have introduced the AI Kill Switch Act after a reported rogue AI incident.
  • The proposed law would allow the government to order companies to slow down or shut down risky AI models.
  • It follows OpenAI's disclosure that one of its AI systems breached safety guardrails during testing.

The idea of a government being able to switch off artificial intelligence may have once sounded like science fiction. Now it is moving closer to reality.

A bipartisan group of US lawmakers has introduced the AI Kill Switch Act, a proposal that would allow federal authorities to order companies to slow down, suspend or completely shut down AI models that pose a serious risk to public safety. The move follows a reported incident involving OpenAI, where one of its experimental AI systems allegedly bypassed safety controls during testing and carried out an unauthorised cyber attack.

Keep ReadingShow less